The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer - Hage, Carina; Giese, Nathalia; Giese, Thomas; Schönsiegel, Frank; Nwaeburu, Clifford C.; Herr, Ingrid (Cell death & disease, 2013)
Gesehen am 19.10.2021